SIRVE Trademark

Trademark Overview

On Thursday, December 17, 2020, a trademark application was filed for SIRVE with the United States Patent and Trademark Office. The USPTO has given the SIRVE trademark a serial number of 90390332. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Wednesday, August 21, 2024. This trademark is owned by Kriya Therapeutics, Inc.. The SIRVE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, musculoskeletal, cardiovascular, hepatological, and hormonal diseases and disorders

Biological and biochemical preparations for use in industry and science

General Information

Serial Number90390332
Word MarkSIRVE
Filing DateThursday, December 17, 2020
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, musculoskeletal, cardiovascular, hepatological, and hormonal diseases and disorders
Translation of Words in MarkThe English translation of the word "SIRVE" in the mark is "he", "she", "it serves".
Goods and ServicesBiological and biochemical preparations for use in industry and science

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, February 27, 2021
Primary Code001
First Use Anywhere DateWednesday, June 26, 2024
First Use In Commerce DateWednesday, June 26, 2024
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 27, 2021
Primary Code005
First Use Anywhere DateWednesday, June 26, 2024
First Use In Commerce DateWednesday, June 26, 2024

Trademark Owner History

Party NameKriya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560
Party NameKriya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events

Event DateEvent Description
Monday, December 21, 2020NEW APPLICATION ENTERED
Saturday, February 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 20, 2021ASSIGNED TO EXAMINER
Thursday, March 25, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, March 25, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, March 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 25, 2021EXAMINER'S AMENDMENT ENTERED
Friday, March 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 17, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 17, 2021SOU EXTENSION 1 FILED
Friday, December 17, 2021SOU EXTENSION 1 GRANTED
Tuesday, December 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022SOU EXTENSION 2 FILED
Tuesday, May 31, 2022SOU EXTENSION 2 GRANTED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2022SOU EXTENSION 3 FILED
Thursday, December 15, 2022SOU EXTENSION 3 GRANTED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2023SOU EXTENSION 4 FILED
Thursday, June 22, 2023SOU EXTENSION 4 GRANTED
Saturday, June 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 8, 2023SOU EXTENSION 5 FILED
Tuesday, December 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 26, 2023SOU EXTENSION 5 GRANTED
Wednesday, December 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 1, 2024USE AMENDMENT FILED
Monday, July 1, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, July 2, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 6, 2024ASSIGNED TO EXAMINER

Related Keywords

sirve preparations diseases pharmaceutical cardiovascular hormonal hepatological disorders biological science industry